Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca looks to revive experimental drugs
Financial Times, UK
Sunday, May 20, 2012 - 12:34pm
tags:
AstraZeneca, R&D
China Biotech Week In Review: J&J Actively Pursuing M&A In China
Seeking Alpha
Sunday, May 20, 2012 - 12:33pm
tags:
JNJ, M&A, China National Biotech Group, Zhejiang Conba Pharma, Ningbo David Medical Device Co, Ventac Partners, Shanxi Zhendong Pharmaceutical Company, Bristol-Myers Squibb, Novozymes Biopharma, Zhejiang Hisun Pharma, ThermoDox
GlaxoSmithKline completes transaction to increase its ownership in Theravance
PharmPro
Sunday, May 20, 2012 - 12:28pm
tags:
GSK, Theravance, M&A
US bioethics centre queried about ties to drug industry
BioEdge
Sunday, May 20, 2012 - 12:26pm
tags:
painkillers, pain management
JacksonWhite Files Overtime Lawsuit Against Quintiles Commercial U.S., Inc.
Business Review Europe
Sunday, May 20, 2012 - 12:24pm
tags:
overtime lawsuits, lawsuits
Abbott Is Cheap, But AbbVie Will Likely Be Cheaper
Seeking Alpha
Sunday, May 20, 2012 - 11:51am
tags:
Abbott Laboratories, AbbVie
Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Sells
Seeking Alpha
Saturday, May 19, 2012 - 12:36pm
tags:
Halozyme, Novavax, Prolor, Valeant Pharmaceuticals, Myrexis, OPKO Health, Vertex Pharmaceuticals, Edwards Lifesciences, Medivation, Biomarin, Mylan
PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 Mg)
The Street
Saturday, May 19, 2012 - 12:29pm
tags:
PA32540, Omeprazole, Pozen
US FDA okays Ambit Biosciences & Teva's IND for CEP-32496, a novel BRAF inhibitor
Pharmabiz
Saturday, May 19, 2012 - 12:26pm
tags:
Ambit Biosciences, Teva Pharmaceuticals, CEP-32496, cancer, melanoma, lung cancer, thyroid cancer, colon cancer, ovarian cancer
FDA Delays Takeda's Replacement for Actos
Injury Board
Saturday, May 19, 2012 - 12:22pm
tags:
Takeda, Actos, alogliptin, diabetes
AstraZeneca appeal against competition law breach and level of fine imposed on it (in Europe) should be rejected, legal advisor says
Out-Law
Saturday, May 19, 2012 - 12:19pm
tags:
AstraZeneca, legal
Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients
Yahoo/BusinessWire
Saturday, May 19, 2012 - 12:14pm
tags:
Pfizer, Lyrica, fibromyalgia
Should Investors Worry About Arena's Offering?
Motley Fool
Saturday, May 19, 2012 - 12:12pm
tags:
Arena Pharmaceuticals
Investing 101: Biotech Stocks With Insider Buying
Motley Fool
Saturday, May 19, 2012 - 12:11pm
tags:
Incyte, ViroPharma, Halozyme, Ziopharm, QLT Inc
Biogen Idec Inc (BIIB): Today's Featured Health Care Loser
The Street
Saturday, May 19, 2012 - 12:09pm
tags:
Biogen Idec
U.S. Suggests All Baby Boomers Should Get Tested for Hepatitis C
WSJ
Saturday, May 19, 2012 - 12:08pm
tags:
hepatitis C
Tengion Announces Receipt of NASDAQ Staff Deficiency Letter
Yahoo/PR NewsWire
Saturday, May 19, 2012 - 12:07pm
tags:
Tengion
BioTime: A Track Record Of Broken Promises
Seeking Alpha
Saturday, May 19, 2012 - 11:55am
tags:
BioTime
3-S Bio: Unit Volume Rises, Costs Decline
Seeking Alpha
Saturday, May 19, 2012 - 11:54am
tags:
3SBio
Sequenom sinks after Coventry Health decides not to cover tests
Yahoo/theflyonthewall.com
Saturday, May 19, 2012 - 11:52am
tags:
Sequenom, Maternit21 Plus, genetic testing

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.